Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XX Other antibacterials
J01XX13 Gepotidacin
D10879 Gepotidacin mesylate (USAN) <US>
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01998 Gepotidacin
D10879 Gepotidacin mesylate
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
DNA replication inhibitor
D10879 Gepotidacin mesylate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10879
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10879
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10879
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01998 Gepotidacin